Why Use Fluconazole Treatment

One of the nastiest types of infection is fungal infection.  Although they are more likely to grow on the skin, there are more serious ones though that develops in the respiratory system and infect not just the lungs, but also the blood and other parts of the body’s internal structure.  When you develop a fungal infection, it is vital that you treat the infection as soon as possible to prevent further growth, development, and spread of the infection.  Failure to do so may mean longer and costlier treatment.  Fluconazole treatment is needed for treating fungal infection.  Fluconazole treatment is an antifungal medication treatment that you take orally.

Most antifungals are applied on the skin directly to where the infection has developed.  However, if the infection has buried further or deeper in to the skin, or the infection has developed inside of the body, such topical type of antifungal will not work on such.  For cases like this, fluconazole treatment is necessary as fluconazole treatment comes in pill form which you take orally.  The treatment process in using fluconazole treatment is the purging of the infection from the inside of your body.  This effectively gets rid of the infection from your system.

For antifungal fluconazole treatment, it is necessary that you use fluconazole treatment for a course of several days.  The number of days you need to use fluconazole treatment depends on the type of infection that you have developed and the severity that it has.  Course treatment is necessary in completely getting rid of an infection from the body.  This is the very reason why doctors prescribe patients with several days of use of fluconazole treatment when they have a fungal infection.  By completing the course of fluconazole treatment, you will be able to completely purge the fungal infection out of the body. Read more…

Relistor may weaken the GI wall

When to beware

As all meds do, mythylnaltrexone bromide (Relistor) has its share of possible side effects, the most common being dizziness, flatulence, mild diarrhea, nausea, stomach pain, vomiting, and hyperhidrosis. Severe reactions include a serious case of any already mentioned, or allergic reactions.

Today, Health Canada and Wyeth Canada added a new possible adverse reaction to the list: a heightened risk of gastrointestinal perforation, especially in those with GI cancers and other conditions that could weaken the gastrointestinal wall.

When Relistor came onto the scene – it was approved by Health Canada on March 28, 2008 – it relieved opioid-induced constipation in palliative-care patients with incurable cancers, end-stage COPD from emphysema, heart failure, Alzheimer’s disease, and so on, when other laxative therapies could not – in under 30 minutes. Administered by subcutaneous injection, it blocks opioids from entering cells, allowing bowels to revert to normal function, while not interfering with the opioid’s ability to relieve pain.

The current warning advises discontinuing Relistor and seeking professional help if severe, persistent symptoms like abdominal pain intensified by movement, nausea and vomiting -- possibly accompanied by fever and chills – worsen, as these can be signs of GI perforation.

It makes one wonder, though, if the original studies on this drug should have lasted a wee bit longer than four months.
Milena Katz